GBM - Glioblastoma multiforme Back

External References: Wikipedia National Cancer Institute Google Scholar

iCoMut Beta for


Highly significantly mutated genes
PTEN
90 patients (30%)
TP53
84 patients (28%)
EGFR
77 patients (26%)
PIK3R1
33 patients (11%)
PIK3CA
32 patients (10%)
NF1
32 patients (10%)
RB1
24 patients (8%)
IDH1
15 patients (5%)
STAG2
12 patients (4%)
RPL5
8 patients (2%)
SLC26A3
7 patients (2%)
Significantly mutated genes
MUC17
22 patients (7%)
KEL
15 patients (5%)
CHD8
9 patients (3%)
NUP210L
8 patients (2%)
BRAF
6 patients (2%)
MAP3K1
6 patients (2%)
QKI
5 patients (1%)
AZGP1
5 patients (1%)
SETD2
5 patients (1%)
CD1D
4 patients (1%)
DDX5
4 patients (1%)
Genes near significance
IL4R
8 patients (2%)
BCOR
7 patients (2%)
PAN3
6 patients (2%)
AFM
6 patients (2%)
CD209
5 patients (1%)
SMC1A
5 patients (1%)
PTPN11
5 patients (1%)
GLT8D2
4 patients (1%)
EZR
4 patients (1%)
ODF4
3 patients (1%)
ZDHHC4
3 patients (1%)
PRKCD
3 patients (1%)
Click on a gene to see details.

Notes


• Gene name color indicates: known cancer genes | highly compelling novel candidate cancer genes | other candidates

Data details


Mutation list for GBM
Q-Q plots for GBM